Related Experiment Video
Updated: Jun 27, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Chemotherapy-induced takotsubo cardiomyopathy
Luke Kim1, Maria Karas, S Chiu Wong
1Division of Cardiology, New York, Presbyterian Hospital Weill Cornell Medical Center, Starr Pavillion 4, New York, NY 10021, USA.
Abstract:
Two patients presented with takotsubo cardiomyopathy after chemotherapy. Neither of the patients had any known cardiac history until the initiation of chemotherapy. These patients were treated with different chemotherapy regimens appropriate to their malignancies. After chemotherapy initiation, they presented with symptoms ranging from exertional dyspnea to cardiogenic shock requiring intra-aortic balloon pump and pressor support. Cardiac catheterization demonstrated characteristic apical ballooning with nonobstructive coronary artery disease. Both of the patients demonstrated a transient reduction in left ventricular function which resolved on follow-up echocardiography. These cases suggest a potential novel etiology for takotsubo cardiomyopathy.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care

